AU2013212209A8 - (1R,4R) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof - Google Patents

(1R,4R) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof

Info

Publication number
AU2013212209A8
AU2013212209A8 AU2013212209A AU2013212209A AU2013212209A8 AU 2013212209 A8 AU2013212209 A8 AU 2013212209A8 AU 2013212209 A AU2013212209 A AU 2013212209A AU 2013212209 A AU2013212209 A AU 2013212209A AU 2013212209 A8 AU2013212209 A8 AU 2013212209A8
Authority
AU
Australia
Prior art keywords
azabicyclo
ene
oxo
oct
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2013212209A
Other versions
AU2013212209A1 (en
Inventor
Robert M. Moriarty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DemeRx Inc
Original Assignee
DemeRx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DemeRx Inc filed Critical DemeRx Inc
Publication of AU2013212209A1 publication Critical patent/AU2013212209A1/en
Publication of AU2013212209A8 publication Critical patent/AU2013212209A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/20—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

This invention provides novel (1R,4R) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof, preferably in substantially enantiomerically enriched forms, intermediates thereto, and processes of their synthesis.
AU2013212209A 2012-01-25 2013-01-23 (1R,4R) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof Abandoned AU2013212209A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261741798P 2012-01-25 2012-01-25
US61/741,798 2012-01-25
PCT/US2013/022797 WO2013112622A1 (en) 2012-01-25 2013-01-23 (1r,4r) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof

Publications (2)

Publication Number Publication Date
AU2013212209A1 AU2013212209A1 (en) 2014-06-26
AU2013212209A8 true AU2013212209A8 (en) 2014-07-10

Family

ID=48873876

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013212209A Abandoned AU2013212209A1 (en) 2012-01-25 2013-01-23 (1R,4R) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof

Country Status (11)

Country Link
US (2) US20130267710A1 (en)
EP (1) EP2807158A4 (en)
JP (1) JP2015506371A (en)
KR (1) KR20140117380A (en)
CN (2) CN108912117A (en)
AU (1) AU2013212209A1 (en)
CA (1) CA2857969A1 (en)
HK (1) HK1204615A1 (en)
IL (1) IL233055A (en)
RU (1) RU2014124531A (en)
WO (1) WO2013112622A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014143201A1 (en) 2013-03-15 2014-09-18 Demerx, Inc. Method for noribogaine treatment of addiction in patients on methadone
US9561232B2 (en) 2014-02-18 2017-02-07 Demerx, Inc. Low dose noribogaine for treating nicotine addiction and preventing relapse of nicotine use
US9591978B2 (en) 2014-03-13 2017-03-14 Demerx, Inc. Methods and compositions for pre-screening patients for treatment with noribogaine
WO2015195673A2 (en) * 2014-06-18 2015-12-23 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them
US9549935B2 (en) 2014-07-14 2017-01-24 Demerx, Inc. Methods and compositions for treating migraines using noribogaine
EP4279134A1 (en) 2014-11-26 2023-11-22 DemeRx, Inc. Methods and compostions for potentiating the action of opioid analgesics using iboga alkaloids

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5929247A (en) * 1994-10-24 1999-07-27 Eli Lilly And Company Heterocyclic compounds and their preparation and use
FR2884516B1 (en) * 2005-04-15 2007-06-22 Cerep Sa NPY ANTAGONISTS, PREPARATION AND USES
JP2010229097A (en) * 2009-03-27 2010-10-14 Tohoku Univ New oxazolidine derivative, new oxazolidine derivative salt and method for producing optically active compound using the oxazolidine derivative salt as asymmetric organic molecular catalyst
JP5622019B2 (en) * 2009-09-25 2014-11-12 国立大学法人東北大学 Asymmetric organic molecular catalyst having amino alcohol derivative salt structure and method for producing optically active compound using said asymmetric organic molecular catalyst
WO2013028999A1 (en) * 2011-08-24 2013-02-28 The Trustees Of Columbia University In The City Of New York Small molecule inducers of gdnf as potential new therapeutics for neuropsychiatric disorders

Also Published As

Publication number Publication date
CN108912117A (en) 2018-11-30
CN104169279A (en) 2014-11-26
KR20140117380A (en) 2014-10-07
CA2857969A1 (en) 2013-08-01
EP2807158A4 (en) 2015-11-18
RU2014124531A (en) 2016-04-10
US20130267710A1 (en) 2013-10-10
JP2015506371A (en) 2015-03-02
AU2013212209A1 (en) 2014-06-26
EP2807158A1 (en) 2014-12-03
US20180319800A1 (en) 2018-11-08
HK1204615A1 (en) 2015-11-27
WO2013112622A1 (en) 2013-08-01
IL233055A (en) 2017-02-28
IL233055A0 (en) 2014-08-03

Similar Documents

Publication Publication Date Title
AU2016204248A1 (en) Boron-Containing Molecules
PH12017501139A1 (en) Novel modulators and methods of use
MD20150091A2 (en) Anti-viral compounds
MX2011009369A (en) Substituted 2-mercaptoquinoline-3-carboxamides as kcnq2/3 modulators.
AU2010233994A8 (en) Bispecific anti-ErbB-3/anti-c-Met antibodies
PH12014502010A1 (en) Bispecific antibodies against human tweak and human il17 and uses thereof
WO2013151668A3 (en) Modified polynucleotides for the production of secreted proteins
MX356337B (en) Antibodies against human csf-1r and uses thereof.
MX2011008262A (en) Substituted spiro-amides as b1r modulators.
EA024842B9 (en) Compounds as modulators of pi3k protein kinase
MX336682B (en) Antibodies against human csf-1r and uses thereof.
MY173795A (en) Novel benzopyran kinase modulators
TN2012000414A1 (en) Forms of rifaximin and uses thereof
WO2012174158A3 (en) Administration of benzodiazepine
MX2013000958A (en) Manufacture of inter -alpha - inhibitor proteins (iaip) from plasma.
MX2011008825A (en) Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators.
AU2013212209A8 (en) (1R,4R) 7-oxo-2-azabicyclo[2.2.2]oct-5-ene and derivatives thereof
WO2009115084A3 (en) Pyrrolopyrimidine derivatives, and use thereof
WO2013080217A3 (en) Crystalline forms of carbazitaxel and process for preparation thereof
MX2014002996A (en) Bispecific anti-egfr/anti igf-1r antibodies.
MX2011008662A (en) Substituted 2-mercapto-3-aminopyridines as kcnq2/3 modulators.
MX2011009338A (en) Substituted 3-amino-2-mercaptoquinolines as kcnq2/3 modulators.
IN2013MN00733A (en)
WO2013072933A3 (en) Process for preparation of 2-acetamido-n-benzyl-3-methoxypropionamide
MX339772B (en) Method and composition for reducing the color of sugar.

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 28 , NO 25 , PAGE(S) 3335 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME DEMERX, INC., APPLICATION NO.2013212209, UNDER INID (54) CORRECT THE TITLE TO READ (1R,4R) 7-OXO-2-AZABICYCLO(2.2.2)OCT-5-ENE AND DERIVATIVES THEREOF

MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application